Grassley criticizes FDA over ethics of blood substitute testing

03/14/2006 | Chicago Tribune (tiered subscription model)

Sen. Chuck Grassley, R-Iowa, says the FDA ignored for two years concerns of the Office for Human Research Protections about the risks of tests of a blood substitute without patient consent. Northfield Laboratories' trial involves giving Polyheme to trauma victims.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC